CooperCompanies to buy Generate Life Sciences for $1.6bn

CooperCompanies has agreed to acquire Generate Life Sciences, a provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage. T

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this